Clinical Factors Predicting Bilateral Lymph Node Invasion in High-Risk Prostate Cancer

Urol Int. 2017;99(4):392-399. doi: 10.1159/000476039. Epub 2017 May 10.

Abstract

Background: In high-risk prostate cancer (HR-PCA), it is important to consider the factors associated with extensive lymph node invasion (LNI) before planning treatment methods.

Objective: To investigate clinical predictors of bilateral LNI in HR-PCA.

Materials and methods: The study evaluated 261 consecutive patients who underwent radical prostatectomy with extended pelvic lymph node dissection. The multivariate multinomial logistic regression model was computed.

Results: The high-risk category included 102 cases. Overall, LNI was detected in 28 patients (27.5%) and was bilateral in 11 cases (10.8%). Independent factors associated with LNI were prostate-specific antigen (PSA) and proportion of positive cores. The main model showed that only higher values of PSA increased the odds of bilateral LNI when compared to patients having unilateral LNI (OR 1.058; p = 0.018). The area under the curve of PSA predicting bilateral LNI was 0.819.

Conclusions: In HR-PCA, the independent predictor of LNI was PSA, which varied among patients with bilateral and unilateral LNI.

Keywords: High risk; Lymph node invasion; Prostate biopsy; Prostate cancer; Prostate-specific antigen; Tumor grading system.

MeSH terms

  • Aged
  • Area Under Curve
  • Biopsy
  • Chi-Square Distribution
  • Decision Support Techniques
  • Humans
  • Kallikreins / blood
  • Logistic Models
  • Lymph Node Excision
  • Lymph Nodes / pathology*
  • Lymph Nodes / surgery
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Grading
  • Neoplasm Invasiveness
  • Odds Ratio
  • Predictive Value of Tests
  • Prostate-Specific Antigen / blood
  • Prostatectomy
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / surgery
  • ROC Curve
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors

Substances

  • KLK3 protein, human
  • Kallikreins
  • Prostate-Specific Antigen